Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1959 1
1965 1
1967 1
1973 1
1974 3
1975 1
1976 2
1977 1
1978 1
1980 1
1981 1
1984 1
1985 1
1987 1
1995 1
1996 2
1998 1
1999 1
2001 1
2004 1
2005 2
2006 3
2007 2
2008 13
2009 6
2010 7
2011 5
2012 7
2013 10
2014 10
2015 4
2016 10
2017 10
2018 8
2019 10
2020 18
2021 10
2022 6
2023 9
2024 4
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI Study.
Hart A, Panaccione R, Steinwurz F, Danese S, Hisamatsu T, Cao Q, Ritter T, Seidler U, Olurinde M, Vetter ML, Yee J, Yang Z, Wang Y, Johanns J, Han C, Sahoo A, Terry NA, Sands BE, D'Haens G; GRAVITI Study Group. Hart A, et al. Gastroenterology. 2025 Aug;169(2):308-325. doi: 10.1053/j.gastro.2025.02.033. Epub 2025 Mar 18. Gastroenterology. 2025. PMID: 40113101 Free article. Clinical Trial.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Osty M, Altwegg R, Serrero M, Benezech A, Lecomte A, Cadiot G, Vuitton L, Wampach A, Nancey S, Buisson A, le Berre C, Rouillon C, Gilletta C, Goutorbe F, Fumery M, Hammoudi N, Caillo L, Vidon M, Arab N, Sickersen G, Cavicchi M, Vieujean S, Charkaoui M, Richard N, Wils P, Caron B, Amiot A, Nuzzo A, Laharie D, Kirchgesner J, Uzzan M; GETAID‐J2J group. Osty M, et al. Aliment Pharmacol Ther. 2025 Aug;62(4):430-439. doi: 10.1111/apt.70199. Epub 2025 May 22. Aliment Pharmacol Ther. 2025. PMID: 40400411 Free PMC article.
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial.
Amiot A, Seksik P, Meyer A, Stefanescu C, Wils P, Altwegg R, Vuitton L, Plastaras L, Nicolau A, Pereira B, Duveau N, Laharie D, Mboup B, Boualit M, Allez M, Rajca S, Chanteloup E, Bouguen G, Bazin T, Goutorbe F, Richard N, Moussata D, Vicaut E, Peyrin-Biroulet L. Amiot A, et al. Gut. 2025 Jan 17;74(2):197-205. doi: 10.1136/gutjnl-2024-333281. Gut. 2025. PMID: 39586616 Clinical Trial.
Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study.
Le Cosquer G, Kirchgesner J, Gilletta De Saint Joseph C, Seksik P, Amiot A, Laharie D, Nachury M, Rouillon C, Abitbol V, Nuzzo A, Nancey S, Fumery M, Biron A, Richard N, Altwegg R, Moussata D, Caron B, Vidon M, Reenaers C, Uzzan M, Reimund JM, Serrero M, Simon M, Benezech A, Goutorbe F, Pelletier AL, Caillo L, Vaysse C, Poullenot F; GETAID. Le Cosquer G, et al. Clin Gastroenterol Hepatol. 2025 Sep;23(10):1824-1833.e3. doi: 10.1016/j.cgh.2024.09.034. Epub 2024 Nov 5. Clin Gastroenterol Hepatol. 2025. PMID: 39505240 Free article.
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.
Richard N, Amiot A, Seksik P, Altwegg R, Laharie D, Vuitton L, Nachury M, Bouguen G, Nancey S, Gilletta C, Rouilon C, Coffin B, Allez M, Buisson A, Le Berre C, Uzzan M, Caillo L, Pelletier AL, Peyrin-Biroulet L, Fumery M; GETAID. Richard N, et al. Aliment Pharmacol Ther. 2025 May;61(10):1662-1670. doi: 10.1111/apt.70073. Epub 2025 Mar 4. Aliment Pharmacol Ther. 2025. PMID: 40038887 Free PMC article.
[Hyponatremia and benazepril].
Goutorbe R, Di Sandro I, Colnot F, Louvat M, Demange C. Goutorbe R, et al. Rev Med Interne. 1998 Jul;19(7):519-20. doi: 10.1016/s0248-8663(99)80012-5. Rev Med Interne. 1998. PMID: 9775205 French. No abstract available.
163 results